ArticleJournal of enzyme inhibition and medicinal chemistry2019

Structure-based design generated novel hydroxamic acid based preferential HDAC6 lead inhibitor with on-target cytotoxic activity against primary choroid plexus carcinoma.

Shaymaa E Kassab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.